Skip to main content
. 2021 Jan 29;26(2):e12795. doi: 10.1111/anec.12795

Table 2.

Exemplary validation studies for various mHealth technologies

Device Author n Setting Comparator Sensitivity (%) Specificity (%) Requires ECG confirmation
Pulse palpation Cooke, Doust, and Sanders (2006) 2385 Meta‐analysis 12‐lead ECG 94 72 +
Handheld devices Zenicor Doliwa, Frykman, and Rosenqvist (2009) 100 Outpatient cardiology clinic 12‐lead ECG interpreted by cardiologist 96 92
MyDiagnostick Tieleman (2014) 192 Outpatient cardiology clinic 12‐lead ECG interpreted by cardiologist 100 96
Omron HCG‐801 Kearley et al. (2014) 999 Primary care practices 12‐lead ECG interpreted by cardiologist 94.4 94.6
Merlin ECG event recorders Kearley et al. (2014) 999 Primary care practices 12‐lead ECG interpreted by cardiologist 93.9 90.1
Smartphone ECG device AliveCor Kardia Mobile Lau et al. (2013) 204 Recruited patients 12‐lead ECG interpreted by cardiologist 98 97
Smartphone device PPG CardioRhythm iPhone Chan et al. (2016) 1013 Primary care clinic Single‐lead AliveCor ECG 93 98 +
PULSE‐SMART App McManus et al. (2016) 219 Patients undergoing cardioversion 12‐lead ECG or 3‐channel telemetry 97 94 +
FibriCheck App Proesmans et al. (2019) 223 Primary care practices 12‐lead ECG 95 97 +
Smartwatch ECG KardiaBand automated algorithm Bumgarner et al. (2018) 112 Patients undergoing cardioversion 12‐lead ECG 93 84
Blood pressure device Microlife Wiesel, Fitzig, Herschman, and Messineo (2009) 405 Cardiology outpatients 12‐lead ECG 95, 97 for one or 3 measurements, respectively 86, 89 for one or 3 measurements, respectively +